- Trials with a EudraCT protocol (70)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
70 result(s) found for: Reductase.
Displaying page 1 of 4.
EudraCT Number: 2006-004686-34 | Sponsor Protocol Number: Evaluation Statin Therapy | Start Date*: 2007-02-27 | |||||||||||
Sponsor Name:Karolinska University Hospital | |||||||||||||
Full Title: Evaluation of Statin Therapy- Safety, Effect and Toxicity Mechanisms. | |||||||||||||
Medical condition: Frequency of side effects in patients treated with HMG CoA reductase inhibitors. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006234-34 | Sponsor Protocol Number: CD07/8396 | Start Date*: 2008-08-18 |
Sponsor Name:University of Leeds | ||
Full Title: 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: endothelial and endothelial progenitor cell function in men | ||
Medical condition: Objectives:To investigate whether statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) improve endothelial dysfunction in healthy volunteers (men). Endothelial dysfunction is an ear... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-005143-28 | Sponsor Protocol Number: MED.RES.HOS.2006.03.LP | Start Date*: 2006-12-06 |
Sponsor Name:Medicinsk Forskning | ||
Full Title: Effects of HMG-CoA-reductase inhibition (atorvastatin) on renal sodium excretion, renal hemodynamics, tubular function and vasoactive hormones in healthy subjects under diet with normal and high so... | ||
Medical condition: Healthy volunteer trial | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015955-25 | Sponsor Protocol Number: 1/09 | Start Date*: 2010-02-01 |
Sponsor Name:University Hospital | ||
Full Title: INDIVIDUAL 5-FLUOROURACIL DOSE INDIVIDUALIZATION IN PATIENTS WITH COLORECTAL CANCER | ||
Medical condition: colorectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001529-26 | Sponsor Protocol Number: 20090159 | Start Date*: 2011-07-15 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Randomized, Multicenter Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C, Compared with Ezetimibe, in Hypercholesterolemic Subjects Unable to Tolerate an Effective Dose of a HMG-Co... | |||||||||||||
Medical condition: Hypercholesterolaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) BE (Completed) SE (Completed) DK (Completed) FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004876-19 | Sponsor Protocol Number: 01-05-TL-475-021 | Start Date*: 2006-02-13 | |||||||||||
Sponsor Name:Takeda Europe R&D Centre Ltd | |||||||||||||
Full Title: A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 100 mg or Placebo When Co-Administered With High Dose Statin Therapy in Subjects With Primary Hypercholesterolemia | |||||||||||||
Medical condition: Treatment of patients with primary hypercholesterolemia currently taking atorvastatin (80mg), simvastatin (80mg) or rosuvastatin (40mg) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) ES (Completed) SE (Prematurely Ended) NO (Completed) FI (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011448-20 | Sponsor Protocol Number: 2008.11.007 | Start Date*: 2009-06-22 | |||||||||||
Sponsor Name:Dutch Diabetes Research Foundation | |||||||||||||
Full Title: Hyperoxic exercise training as an innovative therapy to improve metabolic control, endothelial dysfunction and physical fitness in deconditioned type 2 diabetes patients | |||||||||||||
Medical condition: insulin resistance, endothelial dysfunction, cardiovascular fitness, lipid metabolism and glycemic control in deconditioned non-insulin dependent type 2 diabetes patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013622-17 | Sponsor Protocol Number: REMEDY | Start Date*: 2009-10-20 | |||||||||||
Sponsor Name:CARDIOLOGIA UNIVERSITARIA - OSPEDALE CLINICIZZATO SS. ANNUNZIATA - VIA DEI VESTINI - 66013 CHIETI | |||||||||||||
Full Title: ROSUVASTATIN FOR REDUCTION OF MYOCARDIAL DAMAGE AND SYSTEMIC INFLAMMATION DURING CORONARY ANGIOPLASTY - The REMEDY Study | |||||||||||||
Medical condition: In patients with suspected stable CAD candidates to PCI | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002436-82 | Sponsor Protocol Number: EC11-441 | Start Date*: 2012-12-13 |
Sponsor Name:Isabel Pinilla Lozano | ||
Full Title: Melatonin effects on visual and sleep patterns anomalies in subjects diagnosed with Retinitis Pigmentosa | ||
Medical condition: To evaluate the sleep quality in patients with Retinitis Pigmentosa | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006782-83 | Sponsor Protocol Number: EC08/00230 | Start Date*: 2013-09-24 |
Sponsor Name:Hospital Universitario Virgen de las Nieves | ||
Full Title: Prevention MODS by modulating the inflammatory response through melatonin administration in surgical patients with severe sepsis. | ||
Medical condition: Septic patients of abdominal surgery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005508-62 | Sponsor Protocol Number: TRINACRIA | Start Date*: 2015-10-08 | ||||||||||||||||
Sponsor Name:ISTITUTI FISIOTERAPICI OSPITALIERI | ||||||||||||||||||
Full Title: A phase II, randomized, non-comparative, pre-surgical study of atorvastatin or observation in Ki-67 positive, TAZ-expressing early breast cancer patients | ||||||||||||||||||
Medical condition: Early breast cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001007-18 | Sponsor Protocol Number: 2989 | Start Date*: 2005-06-03 |
Sponsor Name:Royal Victoria Infirmary | ||
Full Title: Reversal of warfarin anticoagulation with oral vitamin K: towards a better management of over-anticoagulation | ||
Medical condition: Patients with thromboembolic disorders are anticogulated with warfarin. However excessive over-anticoagulation can increase the patient risk of bleeding. Oral vitamin K is routinely used for revers... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-017060-17 | Sponsor Protocol Number: STIMULATE1.0 | Start Date*: 2009-12-10 |
Sponsor Name:Academic Medical Center | ||
Full Title: STIMULATE study: Statins influence on Minrin upregulation of von Willebrand factor and factor VIII | ||
Medical condition: Type 1 von Willebrand disease and mild hemophilia A | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003041-14 | Sponsor Protocol Number: 565 | Start Date*: 2005-09-20 |
Sponsor Name:Department of Clinical Pharmacology, Medical University of Vienna | ||
Full Title: Anti-inflammatory effect of statins in the human endotoxin model | ||
Medical condition: Healthy volunteers are tested in an endotoxemia model | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002535-12 | Sponsor Protocol Number: kimcl2004-08 | Start Date*: 2004-11-19 |
Sponsor Name:Clinical Institute of Medical and Chemical Laboratory Diagnostics Graz | ||
Full Title: Fluvastatin 80 mg ret. vs combination with ezetimib 10 mg | ||
Medical condition: elevated LDL-C | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002454-37 | Sponsor Protocol Number: RGHT000392 | Start Date*: 2007-07-20 |
Sponsor Name:The Royal Group Hospitals Trust | ||
Full Title: Prevention by HMGCoA reductase inhibition of ALI associated with one lung ventilation following oesophagectomy by a Reduction of Pulmonary vascular dysfunction and inflammation (Prevention-HARP) | ||
Medical condition: Acute lung injury (ALI) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003539-56 | Sponsor Protocol Number: 1.01 | Start Date*: 2006-11-10 |
Sponsor Name:Medical University of Vienna, Department of Internal Medicine IV | ||
Full Title: Simvastatin in patients with septic shock | ||
Medical condition: Septic shock | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006451-52 | Sponsor Protocol Number: 4474 | Start Date*: 2009-01-27 | |||||||||||
Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | |||||||||||||
Full Title: An investigation of the association between vitamin K intake, vitamin K epoxide reductase subunit (VKORC1) genotype and anticoagulation response to warfarin | |||||||||||||
Medical condition: Patients will be recruited who are receiving long term warfarin therapy for the treatment or prevention of venous or arterial thrombosis or embolism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000691-41 | Sponsor Protocol Number: AR001 | Start Date*: 2005-04-11 |
Sponsor Name:Greater Glasgow Health Board, North Glasgow University Hospitals Division | ||
Full Title: Randomised controlled trial to evaluate the effect of statins on asthma control of patients with chronic asthma. | ||
Medical condition: Chronic Asthma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000095-28 | Sponsor Protocol Number: H3E-MC-JMHW | Start Date*: 2017-03-02 |
Sponsor Name:Eli Lilly and Company | ||
Full Title: A Phase II Study of Pemetrexed in Children with Recurrent Malignancies | ||
Medical condition: Recurrent Malignancies (recurrent solid tumors): Target tumor types were osteosarcoma, Ewing sarcoma/peripheral PNET, rhabdomyosarcoma, neuroblastoma (measurable disease), neuroblastoma (metaiodob... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.